MedTrace Logo

The Effect and Safety of Moxibustion Therapy for Overactive Bladder Patients

NCT02271607 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2016-03-14

No results posted yet for this study

Summary

This pragmatic randomized controlled study aimed to evaluate the effectiveness and safety of moxibustion therapy on overactive bladder (OAB) patients.

Conditions

  • Overactive Bladder
  • Hyperthermia
  • Urinary Frequency or Urgency Adverse Event
  • Lower Urinary Tract Symptoms

Interventions

DEVICE

moxibustion

The treatment schedule is three times per week for four weeks. Indirect moxa pillars and indirect-container moxibustion will be used.

Sponsors & Collaborators

  • Korean Medicine Hospital of Pusan National University

    lead OTHER

Principal Investigators

  • Jung Nam Kwon, PhD · Korean Medicine Hospital, Pusan National University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02271607 on ClinicalTrials.gov